2024 SPEAKERS
Mayssa Attar, PhD
Bausch + Lomb
Sharon Bakalash MD, PhD
Astellas Ophthalmics
Robert B. Bhisitkul, MD, PhD
University of California San Francisco School of Medicine
Paul Bresge
Ray Therapeutics
Thomas A. Ciulla, MD, MBA, FASRS
Viridian Therapeutics / Indiana University School of Medicine / Midwest Eye Institute
Liane Clamen, MD
Adaptilens
Karl Csaky, MD, PhD
Retina Foundation of the Southwest
Emmett T. Cunningham Jr., MD, PhD, MPH
Eyconis / HealthQuest Capital Management
Anupam Dalal, MD
Acuta Capital Partners
Eugene de Juan, MD
UCSF Department of Ophthalmology
Pravin U. Dugel, MD
Ocular Therapeutix
David Esposito
ONL Therapeutics
Daniela Ferrara, MD, MS, PhD, FASRS
Genentech a member of the Roche Group
Cedric Francois, MD, PhD
Apellis
Andrew Gitkin
Leerink Partners
Adrienne Graves, PhD
Glaucoma 360
Jason Jun
Citi
Morgan Micheletti, MD, FACS
Berkeley Eye Center
James C. Murray
ExSight Ventures
Ram Palanki, PharmD
REGENXBIO
Jai G. Parekh, MD, MBA
Nordic Pharma Eye Care
Firas Rahhal, MD
ExSight Ventures & Retina Vitreous Associates Medical Group
Robert Rothman, MD
InFocus Capital Partners / OCLI/Glaucoma Consultants of Long Island
Zach Scheiner, PhD
RA Capital Management
Jessica Steen, OD, FAAO
Nova Southeastern University
Andrew Stewart
Bausch + Lomb
Cari Stone
Elios Vision
Cameron Taylor
BofA Securities | Life Sciences
Anthony Wallace
Bausch + Lomb
Robert N. Weinreb, MD
Shiley Eye Institute